We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Ultraminiature SFDI System for Micro-Endoscopy Enables Early Diagnosis of GI Cancers

By HospiMedica International staff writers
Posted on 06 Feb 2024

Gastrointestinal cancers (GCs) rank among the most prevalent cancer types and contribute to a significant proportion of cancer-related deaths globally. More...

Early detection is key to reducing mortality rates associated with GCs, and endoscopic screening is effective in identifying potentially malignant tumors. For widespread application of screening programs, the imaging technology used must be cost-effective to produce and operate, while maintaining high accuracy to ensure low rates of missed diagnoses. To achieve this, researchers have been exploring various imaging techniques, including promising spatial frequency domain imaging (SFDI). SFDI involves projecting a repeating 2D light pattern onto the target area and analyzing the intensity of the reflected light patterns to deduce information about the tissue's optical properties, aiding in the detection of cancerous lesions. Despite its simplicity and affordability, the large size of current SFDI systems makes them too large to fit inside standard endoscopes, limiting their application in GC screening.

Now, researchers from University of Nottingham (Nottingham, UK) have developed a new SFDI device for gastrointestinal endoscopy, potentially expanding access to GC screening. Existing systems are unsuitable for regular endoscopic use in the gastrointestinal tract due to their reliance on expensive and large digital micromirror device-based projectors, low-quality pattern production using fiber bundles, or the inflexibility of rigid endoscopes. To address these challenges, the team developed an ultraminiature SFDI system using a custom optic fiber bundle as a projector. This bundle consists of seven individual optic fibers, each connectable to laser sources of varying wavelengths.

The system generates a 2D sinusoidal pattern on the target tissue by feeding a single laser wavelength into two different fibers, exploiting the interference phenomenon. By selecting different fiber pairs, the spatial characteristics of the pattern can be adjusted, and patterns with up to three wavelengths (like green, red, and blue) can be projected simultaneously. Coupled with an ultraminiature camera (1 mm x 1 mm), the researchers have assembled a prototype SFDI system just 3 mm in diameter. A custom algorithm further refines the system by tracking phase deviations in the projected patterns, enhancing the absorption and scattering profiles' clarity.

Tests with tissue phantoms mimicking healthy and cancerous tissues demonstrated the device's ability to clearly differentiate between the two types. The specificity and sensitivity rates for detecting squamous cell carcinoma were over 90%, comparable to current medical device standards. The researchers believe the system could be further miniaturized to a diameter of 1.5 mm, allowing for even less invasive endoscopic procedures. Its capacity for multi-wavelength imaging means it can capture optical information at various tissue depths, facilitating simultaneous analysis of multiple tissue layers. These findings highlight the potential of this novel imaging method for diagnostic purposes in gastrointestinal cancer detection.

“Our prototype shows promise as a cost-effective, quantitative imaging tool to detect variations in optical absorption and scattering as indicators of cancer,” said researcher Jane Crowley from University of Nottingham. “This work could form the basis of new devices suitable for cost-effective endoscopic deployment for screening of gastrointestinal cancers.”

Related Links:
University of Nottingham


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
New
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image

Explainable AI Tool Improves Brain Disorder Screening from 4D fMRI

Functional magnetic resonance imaging (fMRI) captures changes in brain activity over time, but the resulting image sequences can be difficult to analyze. Screening for brain disorders requires assessing... Read more

Critical Care

view channel
Image: Liposomes have long been used for gradual drug delivery, with their composition controlling release speed, potency, duration, and potential toxicity. (Image Credit: iStock)

New Drug Delivery System Extends Release of Local Anesthetic for Weeks

Local anesthetics used for nerve blocks often provide pain relief for only a limited period, while perioperative pain can persist much longer. Extending the duration of a nerve block therefore requires... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.